The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 66 | 17.6x | 20.1x | Near average | |
Growth | 90 | 37.0% | 5.6% | Above average | |
Quality | 68 | 17.6% | 7.6% | Above average | |
Safety | 46 | 0.0x | 0.4x | Near average | |
Capital Return | 42 | 0.04% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
ANI Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy ANI Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
ANIP stock shows a state of complete and rare consensus among analysts, as the price target has stabilized at 124 dollars without any change over the past periods (7 and 30 days). The lack of dispersion between the high and low price targets indicates a completely unified vision by the following analysts, reflecting high confidence in the estimated fair value of the stock compared to its current price of 82.72 dollars.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.